What amount sold does pHLIP, Inc. report in Form D filings?

The latest linked filings report $7.9M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was pHLIP, Inc.'s most recent SEC filing?

pHLIP, Inc.'s most recent Form D filing was on 2018-10-30.

How many investors does pHLIP, Inc. have?

The most recent Form D filing lists 5 investor(s).

What type of securities does pHLIP, Inc. offer?

pHLIP, Inc.'s SEC Form D filings indicate equity offerings.

pHLIP, Inc.

CIK: 0001716125·Biotechnology·KINGSTON, RI·Corporation·Founded 2014

Reported Sold

$7,859,645

Total Filings

Identified Offerings

Last Filed

Oct 30, 2018

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 30, 2018Form D — New notice

Reported sold: $4,411,441 · Target: $4,411,441

Rule 506(b)·5 investors

Sep 5, 2017Form D — New notice

Reported sold: $3,448,204 · Target: $3,448,204

Rule 506(b)·5 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$7,859,645

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

OLEG A. ANDREEV

Related Person

Appears on 2 filings

DONALD ENGELMAN

Related Person

Appears on 2 filings

YANA K. RESHETNYAK

Related Person

Appears on 2 filings

JASON LEWIS

Related Person

Appears on 2 filings

DANIEL GREENBERG

Related Person

Appears on 1 filing

DOUGLAS KARP

Related Person

Appears on 1 filing

BRIAN NATH

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 30, 2018	New	$4,411,441	$4,411,441	5
Sep 5, 2017	New	$3,448,204	$3,448,204	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

HealthVest Fund V LLC

Biotechnology

Offering target: $6,000,000

Filed Nov 5, 2026